Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference18 articles.
1. Platelet reactivity characterized prospectively;Kabbani;Circulation,2001
2. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation;N Engl J Med,1994
3. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous revascularization;N Engl J Med,1997
4. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators;Tcheng;Circulation,1995
5. Randomised placebo-controlled trial of the effect of integrilin on complications of PTCA;Lancet,1997
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction;Circulation;2020-08-04
2. Meta-Analysis of Randomized Controlled Trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention;The Anatolian Journal of Cardiology;2020
3. The Prognostic Value of ADP-Induced Platelet Aggregation for Bleeding Complications in Low – Intermediate Risk Patients with Acute Coronary Syndrome Taking Clopidogrel After Percutaneous Coronary Intervention;Heart, Lung and Circulation;2017-01
4. High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study;EuroIntervention;2015-02
5. Impact of upstream high bolus dose tirofiban on left ventricular systolic function in patients with acute anterior myocardial infarction treated by primary coronary intervention;The Egyptian Heart Journal;2014-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3